NLRP3 and Alzheimer disease: Evidences have suggested that NBP treatment could exert neuroprotective actions by enhancing anti-oxidation and attenuating mitochondrial dysfunction in models of ischemic stroke and could inhibit NLRP3 inflammasome activation via upregulating Nrf2 in AD models (45, 46).